TORRENT PHARMACEUTICALS
Back to Income Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Total Expenditure History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹9,607 Cr | ₹7,812 Cr | ₹7,364 Cr | ₹6,796 Cr | ₹6,077 Cr |
What is the latest Total Expenditure of TORRENT PHARMACEUTICALS ?
| Year | Total Expenditure |
|---|---|
| Mar2026 | ₹9,607 Cr |
| Mar2025 | ₹7,812 Cr |
| Mar2024 | ₹7,364 Cr |
| Mar2023 | ₹6,796 Cr |
| Mar2022 | ₹6,077 Cr |
How is Total Expenditure of TORRENT PHARMACEUTICALS Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2026 | ₹9,607 Cr | 22.98 | |
| Mar2025 | ₹7,812 Cr | 6.08 | |
| Mar2024 | ₹7,364 Cr | 8.36 | |
| Mar2023 | ₹6,796 Cr | 11.84 | |
| Mar2022 | ₹6,077 Cr | - | |
Compare Total Expenditure of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹157,071.7 Cr | 3.1% | 6.7% | 45.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,704.0 Cr | -0.5% | 3.9% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,684.0 Cr | -3.1% | -0.1% | 0.2% | Stock Analytics | |
| CIPLA | ₹117,699.0 Cr | 1.4% | 4.8% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,792.0 Cr | 0.8% | 3.9% | 1.5% | Stock Analytics | |
| MANKIND PHARMA | ₹102,844.0 Cr | 0.6% | 7.3% | 10.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 3.1% |
6.7% |
45.5% |
| SENSEX | 1% |
2.9% |
-6.1% |
You may also like the below Video Courses